title: The impact of chronic hepatitis C infection on cholesterol metabolism in PBMCs is associated with microRNA-146a expression.
abstract: Chronic hepatitis C (CHC) infection is known to induce important changes in host cholesterol metabolism. MicroRNAs (miRNAs) regulate the expression of many genes and, in consequence, control various processes, including human metabolism and response to viral infection. Recently, the alteration of the immune-associated miR-146a, which is abundantly present in peripheral blood mononuclear cells (PBMCs), was found in some viral infections. The study aimed to analyse the influence of hepatitis C virus (HCV) infection on miR-146a expression in PBMCs in vivo and in vitro, as well as to assess the possible impact of miR-146a alteration on the intracellular cholesterol level in PBMCs. Blood samples collected from 42 healthy donors and 72 CHC patients were the source of materials. HCV RNA, intracellular cholesterol level and miR-146a expression were determined in PBMCs, as well as HCV genotype and interferon (IFN)α concentration in sera. The influence of miR-146a inhibition on cholesterol expression in PBMCs was analysed in vitro after transient cell transfections with mirVana™ anti-miR-146a Inhibitor. Our data demonstrated an alteration of miR-146a and intracellular cholesterol expression in PBMCs and of IFNα concentration in sera of genotype 1, HCV-infected patients compared to the healthy donors. Also, in cultured PBMCs, miR-146a expression and intracellular cholesterol level were significantly decreased in CHC patients compared to the healthy donors. In vitro blockage of miR-146a expression in PBMCs of CHC patients greatly impaired intracellular cholesterol expression. In these conditions, miR-146a expression was positively correlated with the intracellular cholesterol level. These results suggest that genotype 1 HCV infection may alter miR-146a expression in PBMCs and, consequently, contribute to the observed dysregulation of cholesterol synthesis.
authors.affiliation: Department of Medical Biochemistry, Medical University of Lodz, Mazowiecka str. 6/8, 92-215, Lodz, Poland. malgorzata.sidorkiewicz@umed.lodz.pl.
authors.forename: M
authors.initials: M
authors.lastname: Sidorkiewicz
authors.affiliation: Department of Medical Biochemistry, Medical University of Lodz, Mazowiecka str. 6/8, 92-215, Lodz, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Grek
authors.affiliation: Department of Medical Biochemistry, Medical University of Lodz, Mazowiecka str. 6/8, 92-215, Lodz, Poland.
authors.forename: B
authors.initials: B
authors.lastname: Jozwiak
authors.affiliation: Department of Medical Biochemistry, Medical University of Lodz, Mazowiecka str. 6/8, 92-215, Lodz, Poland.
authors.forename: A
authors.initials: A
authors.lastname: Krol
authors.affiliation: Department of Infectious Diseases and Hepatology, Medical University of Lodz, Lodz, Poland.
authors.forename: A
authors.initials: A
authors.lastname: Piekarska
mesh_terms: D000328:Adult; D002784:Cholesterol / Q000032:analysis*; D005260:Female; D015870:Gene Expression; D005838:Genotype; D016174:Hepacivirus / Q000145:classification / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000473:pathology*; D006801:Humans; D016898:Interferon-alpha / Q000097:blood; D007963:Leukocytes, Mononuclear / Q000737:chemistry*; D008297:Male; D035683:MicroRNAs / Q000032:analysis* / Q000235:genetics; D055815:Young Adult
chemical_list: D016898:Interferon-alpha; C542542:MIRN146 microRNA, human; D035683:MicroRNAs; D002784:Cholesterol